FDA Cardio-Renal Drugs Panel Will Discuss Pre-Dialysis Use For Phosphate Binders
This article was originally published in The Pink Sheet Daily
Executive Summary
The Oct. 16-17 meeting will also discuss data requirements, study designs for pediatric indication for Pfizer’s Revatio in PAH.